Lataa...
Isoniazid or Moxifloxacin in Rifapentine-based Regimens for Experimental Tuberculosis?
Rationale: Recent studies have demonstrated that combined substitutions of rifapentine for rifampin and moxifloxacin for isoniazid in the standard, daily, short-course regimen of rifampin, isoniazid, and pyrazinamide produces stable cure in 12 weeks or less. This study was designed to more precisely...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Thoracic Society
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2577731/ https://ncbi.nlm.nih.gov/pubmed/18723432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.200807-1029OC |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|